Quarterly Results

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE290.751.2 (+0.41 %)
PREV CLOSE ( ) 289.55
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 238597
TODAY'S LOW / HIGH ( )288.00 293.50
52 WK LOW / HIGH ( )217.5 307
NSE291.652.05 (+0.71 %)
PREV CLOSE( ) 289.60
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 291.65 (3832)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7923803
TODAY'S LOW / HIGH( ) 287.85 293.70
52 WK LOW / HIGH ( )217.5 307.1
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
39537
34623
34226
37739
Total Expenditure
30269
27207
27082
27766
PBIDT (Excl OI)
9268
7416
7144
9973
Other Income
5655
1579
935
1549
Operating Profit
14923
8995
8079
11522
Interest
2667
2477
2330
2488
Exceptional Items
212
-240
NA
-30
PBDT
12468
6278
5749
9004
Depreciation
4145
3893
3580
3637
Profit Before Tax
8323
2385
2169
5367
Tax
549
416
348
821
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
7774
1969
1821
4546
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
7774
1969
1821
4546
Minority Interest
-933
-471
-475
-1013
Shares of Associates
-241
-242
-332
-401
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
6600
1256
1014
3132
Equity Capital
6003
6003
6003
6003
Face Value (IN RS)
5
5
5
5
Reserves
NA
NA
NA
NA
Calculated EPS
5.49
1.04
0.84
2.60
Calculated EPS (Annualised)
21.98
4.18
3.37
10.43
No of Public Share Holdings
472575824
472575824
472575824
472575824
% of Public Share Holdings
39.36
39.36
39.36
39.36
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
23.44
21.41
20.87
26.42
PBIDTM%
37.74
25.97
23.60
30.53
PBDTM%
31.53
18.13
16.79
23.85
PBTM%
21.05
6.88
6.33
14.22
PATM%
19.66
5.68
5.32
12.04
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.